Request for Covid-19 Impact Assessment of this Report
The United States Biothrax (Anthrax Vaccine) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biothrax (Anthrax Vaccine) market, reaching US$ million by the year 2028. As for the Europe Biothrax (Anthrax Vaccine) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Biothrax (Anthrax Vaccine) players cover Merial, Merck, Zoetis, and Bayer Sanidad Animal, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Biothrax (Anthrax Vaccine) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Live Vaccines
Cell Free PA Vaccines
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Human Use
Animal Use
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biothrax (Anthrax Vaccine) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Biothrax (Anthrax Vaccine) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Biothrax (Anthrax Vaccine) by Country/Region, 2017, 2022 & 2028
2.2 Biothrax (Anthrax Vaccine) Segment by Type
2.2.1 Live Vaccines
2.2.2 Cell Free PA Vaccines
2.3 Biothrax (Anthrax Vaccine) Sales by Type
2.3.1 Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2017-2022)
2.3.2 Global Biothrax (Anthrax Vaccine) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Biothrax (Anthrax Vaccine) Sale Price by Type (2017-2022)
2.4 Biothrax (Anthrax Vaccine) Segment by Application
2.4.1 Human Use
2.4.2 Animal Use
2.5 Biothrax (Anthrax Vaccine) Sales by Application
2.5.1 Global Biothrax (Anthrax Vaccine) Sale Market Share by Application (2017-2022)
2.5.2 Global Biothrax (Anthrax Vaccine) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Biothrax (Anthrax Vaccine) Sale Price by Application (2017-2022)
3 Global Biothrax (Anthrax Vaccine) by Company
3.1 Global Biothrax (Anthrax Vaccine) Breakdown Data by Company
3.1.1 Global Biothrax (Anthrax Vaccine) Annual Sales by Company (2020-2022)
3.1.2 Global Biothrax (Anthrax Vaccine) Sales Market Share by Company (2020-2022)
3.2 Global Biothrax (Anthrax Vaccine) Annual Revenue by Company (2020-2022)
3.2.1 Global Biothrax (Anthrax Vaccine) Revenue by Company (2020-2022)
3.2.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Company (2020-2022)
3.3 Global Biothrax (Anthrax Vaccine) Sale Price by Company
3.4 Key Manufacturers Biothrax (Anthrax Vaccine) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biothrax (Anthrax Vaccine) Product Location Distribution
3.4.2 Players Biothrax (Anthrax Vaccine) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Biothrax (Anthrax Vaccine) by Geographic Region
4.1 World Historic Biothrax (Anthrax Vaccine) Market Size by Geographic Region (2017-2022)
4.1.1 Global Biothrax (Anthrax Vaccine) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Biothrax (Anthrax Vaccine) Annual Revenue by Geographic Region
4.2 World Historic Biothrax (Anthrax Vaccine) Market Size by Country/Region (2017-2022)
4.2.1 Global Biothrax (Anthrax Vaccine) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Biothrax (Anthrax Vaccine) Annual Revenue by Country/Region
4.3 Americas Biothrax (Anthrax Vaccine) Sales Growth
4.4 APAC Biothrax (Anthrax Vaccine) Sales Growth
4.5 Europe Biothrax (Anthrax Vaccine) Sales Growth
4.6 Middle East & Africa Biothrax (Anthrax Vaccine) Sales Growth
5 Americas
5.1 Americas Biothrax (Anthrax Vaccine) Sales by Country
5.1.1 Americas Biothrax (Anthrax Vaccine) Sales by Country (2017-2022)
5.1.2 Americas Biothrax (Anthrax Vaccine) Revenue by Country (2017-2022)
5.2 Americas Biothrax (Anthrax Vaccine) Sales by Type
5.3 Americas Biothrax (Anthrax Vaccine) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biothrax (Anthrax Vaccine) Sales by Region
6.1.1 APAC Biothrax (Anthrax Vaccine) Sales by Region (2017-2022)
6.1.2 APAC Biothrax (Anthrax Vaccine) Revenue by Region (2017-2022)
6.2 APAC Biothrax (Anthrax Vaccine) Sales by Type
6.3 APAC Biothrax (Anthrax Vaccine) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Biothrax (Anthrax Vaccine) by Country
7.1.1 Europe Biothrax (Anthrax Vaccine) Sales by Country (2017-2022)
7.1.2 Europe Biothrax (Anthrax Vaccine) Revenue by Country (2017-2022)
7.2 Europe Biothrax (Anthrax Vaccine) Sales by Type
7.3 Europe Biothrax (Anthrax Vaccine) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biothrax (Anthrax Vaccine) by Country
8.1.1 Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Biothrax (Anthrax Vaccine) Revenue by Country (2017-2022)
8.2 Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Type
8.3 Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biothrax (Anthrax Vaccine)
10.3 Manufacturing Process Analysis of Biothrax (Anthrax Vaccine)
10.4 Industry Chain Structure of Biothrax (Anthrax Vaccine)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biothrax (Anthrax Vaccine) Distributors
11.3 Biothrax (Anthrax Vaccine) Customer
12 World Forecast Review for Biothrax (Anthrax Vaccine) by Geographic Region
12.1 Global Biothrax (Anthrax Vaccine) Market Size Forecast by Region
12.1.1 Global Biothrax (Anthrax Vaccine) Forecast by Region (2023-2028)
12.1.2 Global Biothrax (Anthrax Vaccine) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biothrax (Anthrax Vaccine) Forecast by Type
12.7 Global Biothrax (Anthrax Vaccine) Forecast by Application
13 Key Players Analysis
13.1 Merial
13.1.1 Merial Company Information
13.1.2 Merial Biothrax (Anthrax Vaccine) Product Offered
13.1.3 Merial Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merial Main Business Overview
13.1.5 Merial Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Biothrax (Anthrax Vaccine) Product Offered
13.2.3 Merck Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Zoetis
13.3.1 Zoetis Company Information
13.3.2 Zoetis Biothrax (Anthrax Vaccine) Product Offered
13.3.3 Zoetis Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Zoetis Main Business Overview
13.3.5 Zoetis Latest Developments
13.4 Bayer Sanidad Animal
13.4.1 Bayer Sanidad Animal Company Information
13.4.2 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Offered
13.4.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Bayer Sanidad Animal Main Business Overview
13.4.5 Bayer Sanidad Animal Latest Developments
13.5 Colorado Serum
13.5.1 Colorado Serum Company Information
13.5.2 Colorado Serum Biothrax (Anthrax Vaccine) Product Offered
13.5.3 Colorado Serum Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Colorado Serum Main Business Overview
13.5.5 Colorado Serum Latest Developments
13.6 PharmAthene
13.6.1 PharmAthene Company Information
13.6.2 PharmAthene Biothrax (Anthrax Vaccine) Product Offered
13.6.3 PharmAthene Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 PharmAthene Main Business Overview
13.6.5 PharmAthene Latest Developments
13.7 Tiankang
13.7.1 Tiankang Company Information
13.7.2 Tiankang Biothrax (Anthrax Vaccine) Product Offered
13.7.3 Tiankang Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Tiankang Main Business Overview
13.7.5 Tiankang Latest Developments
13.8 Biogénesis-Bago
13.8.1 Biogénesis-Bago Company Information
13.8.2 Biogénesis-Bago Biothrax (Anthrax Vaccine) Product Offered
13.8.3 Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Biogénesis-Bago Main Business Overview
13.8.5 Biogénesis-Bago Latest Developments
13.9 CAVAC
13.9.1 CAVAC Company Information
13.9.2 CAVAC Biothrax (Anthrax Vaccine) Product Offered
13.9.3 CAVAC Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 CAVAC Main Business Overview
13.9.5 CAVAC Latest Developments
13.10 Rosenbusch
13.10.1 Rosenbusch Company Information
13.10.2 Rosenbusch Biothrax (Anthrax Vaccine) Product Offered
13.10.3 Rosenbusch Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Rosenbusch Main Business Overview
13.10.5 Rosenbusch Latest Developments
13.11 Agrovet
13.11.1 Agrovet Company Information
13.11.2 Agrovet Biothrax (Anthrax Vaccine) Product Offered
13.11.3 Agrovet Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Agrovet Main Business Overview
13.11.5 Agrovet Latest Developments
13.12 Vecol
13.12.1 Vecol Company Information
13.12.2 Vecol Biothrax (Anthrax Vaccine) Product Offered
13.12.3 Vecol Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Vecol Main Business Overview
13.12.5 Vecol Latest Developments
13.13 CVCRI
13.13.1 CVCRI Company Information
13.13.2 CVCRI Biothrax (Anthrax Vaccine) Product Offered
13.13.3 CVCRI Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 CVCRI Main Business Overview
13.13.5 CVCRI Latest Developments
13.14 IVPM
13.14.1 IVPM Company Information
13.14.2 IVPM Biothrax (Anthrax Vaccine) Product Offered
13.14.3 IVPM Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 IVPM Main Business Overview
13.14.5 IVPM Latest Developments
13.15 Prondil
13.15.1 Prondil Company Information
13.15.2 Prondil Biothrax (Anthrax Vaccine) Product Offered
13.15.3 Prondil Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Prondil Main Business Overview
13.15.5 Prondil Latest Developments
13.16 CDV
13.16.1 CDV Company Information
13.16.2 CDV Biothrax (Anthrax Vaccine) Product Offered
13.16.3 CDV Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 CDV Main Business Overview
13.16.5 CDV Latest Developments
13.17 Indian Immunologicals
13.17.1 Indian Immunologicals Company Information
13.17.2 Indian Immunologicals Biothrax (Anthrax Vaccine) Product Offered
13.17.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Indian Immunologicals Main Business Overview
13.17.5 Indian Immunologicals Latest Developments
13.18 Botswana Vaccine Institute
13.18.1 Botswana Vaccine Institute Company Information
13.18.2 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Offered
13.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Botswana Vaccine Institute Main Business Overview
13.18.5 Botswana Vaccine Institute Latest Developments
13.19 Ceva Santé Animale
13.19.1 Ceva Santé Animale Company Information
13.19.2 Ceva Santé Animale Biothrax (Anthrax Vaccine) Product Offered
13.19.3 Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Ceva Santé Animale Main Business Overview
13.19.5 Ceva Santé Animale Latest Developments
13.20 Intervac
13.20.1 Intervac Company Information
13.20.2 Intervac Biothrax (Anthrax Vaccine) Product Offered
13.20.3 Intervac Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Intervac Main Business Overview
13.20.5 Intervac Latest Developments
13.21 JOVAC
13.21.1 JOVAC Company Information
13.21.2 JOVAC Biothrax (Anthrax Vaccine) Product Offered
13.21.3 JOVAC Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 JOVAC Main Business Overview
13.21.5 JOVAC Latest Developments
14 Research Findings and Conclusion
Table 1. Biothrax (Anthrax Vaccine) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Biothrax (Anthrax Vaccine) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Live Vaccines
Table 4. Major Players of Cell Free PA Vaccines
Table 5. Global Biothrax (Anthrax Vaccine) Sales by Type (2017-2022) & (K Units)
Table 6. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2017-2022)
Table 7. Global Biothrax (Anthrax Vaccine) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2017-2022)
Table 9. Global Biothrax (Anthrax Vaccine) Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Biothrax (Anthrax Vaccine) Sales by Application (2017-2022) & (K Units)
Table 11. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2017-2022)
Table 12. Global Biothrax (Anthrax Vaccine) Revenue by Application (2017-2022)
Table 13. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2017-2022)
Table 14. Global Biothrax (Anthrax Vaccine) Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Biothrax (Anthrax Vaccine) Sales by Company (2020-2022) & (K Units)
Table 16. Global Biothrax (Anthrax Vaccine) Sales Market Share by Company (2020-2022)
Table 17. Global Biothrax (Anthrax Vaccine) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Company (2020-2022)
Table 19. Global Biothrax (Anthrax Vaccine) Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Biothrax (Anthrax Vaccine) Producing Area Distribution and Sales Area
Table 21. Players Biothrax (Anthrax Vaccine) Products Offered
Table 22. Biothrax (Anthrax Vaccine) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Biothrax (Anthrax Vaccine) Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Biothrax (Anthrax Vaccine) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Biothrax (Anthrax Vaccine) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Biothrax (Anthrax Vaccine) Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Biothrax (Anthrax Vaccine) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Biothrax (Anthrax Vaccine) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Biothrax (Anthrax Vaccine) Sales by Country (2017-2022) & (K Units)
Table 34. Americas Biothrax (Anthrax Vaccine) Sales Market Share by Country (2017-2022)
Table 35. Americas Biothrax (Anthrax Vaccine) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2017-2022)
Table 37. Americas Biothrax (Anthrax Vaccine) Sales by Type (2017-2022) & (K Units)
Table 38. Americas Biothrax (Anthrax Vaccine) Sales Market Share by Type (2017-2022)
Table 39. Americas Biothrax (Anthrax Vaccine) Sales by Application (2017-2022) & (K Units)
Table 40. Americas Biothrax (Anthrax Vaccine) Sales Market Share by Application (2017-2022)
Table 41. APAC Biothrax (Anthrax Vaccine) Sales by Region (2017-2022) & (K Units)
Table 42. APAC Biothrax (Anthrax Vaccine) Sales Market Share by Region (2017-2022)
Table 43. APAC Biothrax (Anthrax Vaccine) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2017-2022)
Table 45. APAC Biothrax (Anthrax Vaccine) Sales by Type (2017-2022) & (K Units)
Table 46. APAC Biothrax (Anthrax Vaccine) Sales Market Share by Type (2017-2022)
Table 47. APAC Biothrax (Anthrax Vaccine) Sales by Application (2017-2022) & (K Units)
Table 48. APAC Biothrax (Anthrax Vaccine) Sales Market Share by Application (2017-2022)
Table 49. Europe Biothrax (Anthrax Vaccine) Sales by Country (2017-2022) & (K Units)
Table 50. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Country (2017-2022)
Table 51. Europe Biothrax (Anthrax Vaccine) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2017-2022)
Table 53. Europe Biothrax (Anthrax Vaccine) Sales by Type (2017-2022) & (K Units)
Table 54. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Type (2017-2022)
Table 55. Europe Biothrax (Anthrax Vaccine) Sales by Application (2017-2022) & (K Units)
Table 56. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Biothrax (Anthrax Vaccine)
Table 66. Key Market Challenges & Risks of Biothrax (Anthrax Vaccine)
Table 67. Key Industry Trends of Biothrax (Anthrax Vaccine)
Table 68. Biothrax (Anthrax Vaccine) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Biothrax (Anthrax Vaccine) Distributors List
Table 71. Biothrax (Anthrax Vaccine) Customer List
Table 72. Global Biothrax (Anthrax Vaccine) Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Biothrax (Anthrax Vaccine) Sales Market Forecast by Region
Table 74. Global Biothrax (Anthrax Vaccine) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Biothrax (Anthrax Vaccine) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Biothrax (Anthrax Vaccine) Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Biothrax (Anthrax Vaccine) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Biothrax (Anthrax Vaccine) Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Biothrax (Anthrax Vaccine) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Biothrax (Anthrax Vaccine) Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Biothrax (Anthrax Vaccine) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Biothrax (Anthrax Vaccine) Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Biothrax (Anthrax Vaccine) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Biothrax (Anthrax Vaccine) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Biothrax (Anthrax Vaccine) Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Biothrax (Anthrax Vaccine) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Biothrax (Anthrax Vaccine) Revenue Market Share Forecast by Application (2023-2028)
Table 92. Merial Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 93. Merial Biothrax (Anthrax Vaccine) Product Offered
Table 94. Merial Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Merial Main Business
Table 96. Merial Latest Developments
Table 97. Merck Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck Biothrax (Anthrax Vaccine) Product Offered
Table 99. Merck Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Merck Main Business
Table 101. Merck Latest Developments
Table 102. Zoetis Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 103. Zoetis Biothrax (Anthrax Vaccine) Product Offered
Table 104. Zoetis Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Zoetis Main Business
Table 106. Zoetis Latest Developments
Table 107. Bayer Sanidad Animal Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 108. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Offered
Table 109. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Bayer Sanidad Animal Main Business
Table 111. Bayer Sanidad Animal Latest Developments
Table 112. Colorado Serum Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 113. Colorado Serum Biothrax (Anthrax Vaccine) Product Offered
Table 114. Colorado Serum Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Colorado Serum Main Business
Table 116. Colorado Serum Latest Developments
Table 117. PharmAthene Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 118. PharmAthene Biothrax (Anthrax Vaccine) Product Offered
Table 119. PharmAthene Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. PharmAthene Main Business
Table 121. PharmAthene Latest Developments
Table 122. Tiankang Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 123. Tiankang Biothrax (Anthrax Vaccine) Product Offered
Table 124. Tiankang Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Tiankang Main Business
Table 126. Tiankang Latest Developments
Table 127. Biogénesis-Bago Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 128. Biogénesis-Bago Biothrax (Anthrax Vaccine) Product Offered
Table 129. Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Biogénesis-Bago Main Business
Table 131. Biogénesis-Bago Latest Developments
Table 132. CAVAC Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 133. CAVAC Biothrax (Anthrax Vaccine) Product Offered
Table 134. CAVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. CAVAC Main Business
Table 136. CAVAC Latest Developments
Table 137. Rosenbusch Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 138. Rosenbusch Biothrax (Anthrax Vaccine) Product Offered
Table 139. Rosenbusch Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Rosenbusch Main Business
Table 141. Rosenbusch Latest Developments
Table 142. Agrovet Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 143. Agrovet Biothrax (Anthrax Vaccine) Product Offered
Table 144. Agrovet Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Agrovet Main Business
Table 146. Agrovet Latest Developments
Table 147. Vecol Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 148. Vecol Biothrax (Anthrax Vaccine) Product Offered
Table 149. Vecol Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Vecol Main Business
Table 151. Vecol Latest Developments
Table 152. CVCRI Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 153. CVCRI Biothrax (Anthrax Vaccine) Product Offered
Table 154. CVCRI Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. CVCRI Main Business
Table 156. CVCRI Latest Developments
Table 157. IVPM Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 158. IVPM Biothrax (Anthrax Vaccine) Product Offered
Table 159. IVPM Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. IVPM Main Business
Table 161. IVPM Latest Developments
Table 162. Prondil Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 163. Prondil Biothrax (Anthrax Vaccine) Product Offered
Table 164. Prondil Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Prondil Main Business
Table 166. Prondil Latest Developments
Table 167. CDV Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 168. CDV Biothrax (Anthrax Vaccine) Product Offered
Table 169. CDV Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. CDV Main Business
Table 171. CDV Latest Developments
Table 172. Indian Immunologicals Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 173. Indian Immunologicals Biothrax (Anthrax Vaccine) Product Offered
Table 174. Indian Immunologicals Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 175. Indian Immunologicals Main Business
Table 176. Indian Immunologicals Latest Developments
Table 177. Botswana Vaccine Institute Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 178. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Offered
Table 179. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 180. Botswana Vaccine Institute Main Business
Table 181. Botswana Vaccine Institute Latest Developments
Table 182. Ceva Santé Animale Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 183. Ceva Santé Animale Biothrax (Anthrax Vaccine) Product Offered
Table 184. Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 185. Ceva Santé Animale Main Business
Table 186. Ceva Santé Animale Latest Developments
Table 187. Intervac Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 188. Intervac Biothrax (Anthrax Vaccine) Product Offered
Table 189. Intervac Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 190. Intervac Main Business
Table 191. Intervac Latest Developments
Table 192. JOVAC Basic Information, Biothrax (Anthrax Vaccine) Manufacturing Base, Sales Area and Its Competitors
Table 193. JOVAC Biothrax (Anthrax Vaccine) Product Offered
Table 194. JOVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 195. JOVAC Main Business
Table 196. JOVAC Latest Developments
List of Figures
Figure 1. Picture of Biothrax (Anthrax Vaccine)
Figure 2. Biothrax (Anthrax Vaccine) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biothrax (Anthrax Vaccine) Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Biothrax (Anthrax Vaccine) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Biothrax (Anthrax Vaccine) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Live Vaccines
Figure 10. Product Picture of Cell Free PA Vaccines
Figure 11. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type in 2021
Figure 12. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2017-2022)
Figure 13. Biothrax (Anthrax Vaccine) Consumed in Human Use
Figure 14. Global Biothrax (Anthrax Vaccine) Market: Human Use (2017-2022) & (K Units)
Figure 15. Biothrax (Anthrax Vaccine) Consumed in Animal Use
Figure 16. Global Biothrax (Anthrax Vaccine) Market: Animal Use (2017-2022) & (K Units)
Figure 17. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2017-2022)
Figure 18. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application in 2021
Figure 19. Biothrax (Anthrax Vaccine) Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Company in 2021
Figure 21. Global Biothrax (Anthrax Vaccine) Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Geographic Region in 2021
Figure 23. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2017-2022)
Figure 24. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Country/Region in 2021
Figure 25. Americas Biothrax (Anthrax Vaccine) Sales 2017-2022 (K Units)
Figure 26. Americas Biothrax (Anthrax Vaccine) Revenue 2017-2022 ($ Millions)
Figure 27. APAC Biothrax (Anthrax Vaccine) Sales 2017-2022 (K Units)
Figure 28. APAC Biothrax (Anthrax Vaccine) Revenue 2017-2022 ($ Millions)
Figure 29. Europe Biothrax (Anthrax Vaccine) Sales 2017-2022 (K Units)
Figure 30. Europe Biothrax (Anthrax Vaccine) Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Biothrax (Anthrax Vaccine) Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue 2017-2022 ($ Millions)
Figure 33. Americas Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2021
Figure 34. Americas Biothrax (Anthrax Vaccine) Revenue Market Share by Country in 2021
Figure 35. United States Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Biothrax (Anthrax Vaccine) Sales Market Share by Region in 2021
Figure 40. APAC Biothrax (Anthrax Vaccine) Revenue Market Share by Regions in 2021
Figure 41. China Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2021
Figure 48. Europe Biothrax (Anthrax Vaccine) Revenue Market Share by Country in 2021
Figure 49. Germany Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue Market Share by Country in 2021
Figure 56. Egypt Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Biothrax (Anthrax Vaccine) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Biothrax (Anthrax Vaccine) in 2021
Figure 62. Manufacturing Process Analysis of Biothrax (Anthrax Vaccine)
Figure 63. Industry Chain Structure of Biothrax (Anthrax Vaccine)
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...